A1D5U
Dexmethylphenidate
| Created: | 2024-01-31 |
| Last modified: | 2025-08-25 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 36 |
| Chiral Atom Count | 2 |
| Bond Count | 37 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | Dexmethylphenidate |
| Systematic Name (OpenEye OEToolkits) | methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate |
| Formula | C14 H19 N O2 |
| Molecular Weight | 233.306 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | COC(=O)[CH]([CH]1CCCCN1)c2ccccc2 |
| SMILES | OpenEye OEToolkits | 2.0.7 | COC(=O)C(c1ccccc1)C2CCCCN2 |
| Canonical SMILES | CACTVS | 3.385 | COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | COC(=O)[C@H](c1ccccc1)[C@H]2CCCCN2 |
| InChI | InChI | 1.06 | InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1 |
| InChIKey | InChI | 1.06 | DUGOZIWVEXMGBE-CHWSQXEVSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB06701 |
|---|---|
| Name | Dexmethylphenidate |
| Groups |
|
| Description | Dexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002[A177181]. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant[A177193]. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD)[Label,A177181]. The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture[A177181]. |
| Synonyms |
|
| Brand Names |
|
| Indication | Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label]. |
| Categories |
|
| ATC-Code |
|
| CAS number | 40431-64-9 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Sodium-dependent dopamine transporter | MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP... | unknown | inhibitor |
| Sodium-dependent noradrenaline transporter | MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD... | unknown | inhibitor |
| Sodium-dependent serotonin transporter | METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV... | unknown | inhibitor |
| Carboxylesterase | MWLRAFILATLSASAAW | unknown | substrate |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL827 |
| PubChem | 154101 |
| ChEMBL | CHEMBL827 |
| ChEBI | CHEBI:51860 |
| CCDC/CSD | YEGVIS |














